Described herein are methods and compositions for point of care droplet digital PCR (ddPCR) using large uniform droplets that can be visually analyzed for detection. In one embodiment, the ddPCR reaction is prepared by dispensing a plurality of large uniform droplets using a modified pipette tip hav
Described herein are methods and compositions for point of care droplet digital PCR (ddPCR) using large uniform droplets that can be visually analyzed for detection. In one embodiment, the ddPCR reaction is prepared by dispensing a plurality of large uniform droplets using a modified pipette tip having a specific aspect ratio and one or more surfactants in the aqueous phase.
대표청구항▼
1. A pipette tip for performing rapid droplet digital Polymerase Chain Reaction (ddPCR) assays, the pipette tip comprising a proximal end having a first orifice adapted to be operably connected to a pipette, an elongated main body having a cylindrical sidewall forming an interior axial bore and tape
1. A pipette tip for performing rapid droplet digital Polymerase Chain Reaction (ddPCR) assays, the pipette tip comprising a proximal end having a first orifice adapted to be operably connected to a pipette, an elongated main body having a cylindrical sidewall forming an interior axial bore and tapering longitudinally from the proximal end to a distal end having a second orifice, the second orifice being in communication with the interior axial bore and adapted to allow the passage of fluid therethrough, and the second orifice having an elliptical cross-section with an orifice aspect ratio greater than about 3.5. 2. The pipette tip of claim 1, wherein the second orifice has an orifice aspect ratio ranging from about 3.5 to about 6. 3. The pipette tip of claim 1, wherein the second orifice has an orifice aspect ratio ranging from about 3.5 to about 5. 4. The pipette tip of claim 1, wherein an interior sidewall of the interior axial bore is coated with one or more surfactants. 5. The pipette tip of claim 4, wherein the one or more surfactants comprises a fluorosurfactant in an oil phase. 6. The pipette tip of claim 4, wherein the one or more surfactants comprises a water-soluble surfactant in an aqueous phase. 7. A method for modifying a commercially available pipette tip, the method comprising: (a) selecting a commercially available pipette tip; and(b) deforming the pipette tip orifice circumference to have an orifice aspect ratio of equal to or greater than about 3.5. 8. A modified pipette tip produced by the method of claim 7. 9. A method for manufacturing a pipette tip having an orifice aspect ratio of equal to or greater than about 3.5, the method comprising: (a) providing an injection mold comprising a mold cavity having a geometry configured to generate a pipette tip having an orifice aspect ratio of equal to or greater than about 3.5;(b) contacting the mold cavity with a molten polymer;(c) incubating the molten polymer in the mold cavity for sufficient time to allow the molten polymer to cool and solidify in the mold cavity; and(d) releasing the formed pipette tip from the mold cavity after cooling. 10. A pipette tip produced by the method of claim 9. 11. A method of rapidly generating a plurality of large uniform droplets for performing droplet digital Polymerase Chain Reaction (ddPCR) assays, the method comprising: (a) providing a pipette affixed to a pipette tip having a tip orifice aspect ratio of equal to or greater than about 3.5 and a surfactant coating on an interior axial bore surface of the pipette tip;(b) loading the pipette tip with a PCR reaction mixture; and(c) continuously expelling the PCR reaction mixture from the pipette tip, thereby generating a plurality of large uniform droplets. 12. The method of claim 11, wherein the pipette tip having an orifice aspect ratio of equal to or greater than about 3.5 is generated by: providing a commercially available pipette tip; andapplying sufficient pressure between two surfaces to a longitudinal section of the pipette tip adjacent to and comprising the tip orifice for sufficient time to deform the orifice circumference to have an orifice aspect ratio of equal to or greater than about 3.5. 13. The method of claim 11, wherein the surfactant coating on the interior axial bore of the pipette tip is prepared by contacting the interior axial bore surface of the pipette tip with one or more surfactants, incubating the surfactant for a sufficient period of time to adhere to the interior axial bore surface; and expelling the surfactant. 14. A method of rapidly generating a plurality of large uniform droplets for performing droplet digital Polymerase Chain Reaction (ddPCR) assays, the method comprising: (a) providing a commercially available pipette tip;(b) deforming the pipette tip orifice circumference to have an orifice aspect ratio of equal to or greater than about 3.5;(c) contacting an interior sidewall of an interior axial bore of the pipette tip with one or more surfactants to generate a surfactant coating;(d) loading the pipette tip having an orifice aspect ratio of equal to or greater than about 3.5 and a surfactant coating with a PCR reaction mixture; and(e) continuously expelling the PCR reaction mixture from the pipette tip, thereby generating a plurality of large uniform droplets. 15. The method of claim 14, wherein deforming the pipette tip orifice circumference comprises applying sufficient pressure between two surfaces to a longitudinal section of the pipette tip adjacent to and comprising the tip orifice for sufficient time to deform the orifice circumference to have an orifice aspect ratio of equal to or greater than about 3.5. 16. (canceled) 17. The method of claim 14, wherein the fluorosurfactant comprises RAN-008, Krytox, or a combination thereof at a concentration ranging from about 1 w/v % to about 5 w/v %, in the oil phase of HFE-7500 oil. 18. (canceled) 19. The method of claim 14, further comprising a water-soluble surfactant in an aqueous phase to stabilize the droplets in the oil phase during the ddPCR assay, wherein the water-soluble surfactant is polyoxyalkylene block copolymer surfactant Pluronic F127, Poloxamer 188, or a combination thereof, and is present in the aqueous phase at a concentration of ranging from about 0.01 w/v % to about 1.5 w/v %. 20-22. (canceled) 23. The method of claim 14, wherein the plurality of large uniform droplets comprises individual droplets having a size ranging from about 100 μm to about 400 μm, and comprises between about 1,000 to about 10,000 monodispersed droplets. 24-30. (canceled) 31. The method of claim 14, wherein the plurality of droplets is visually analyzed following the ddPCR assay using a camera or microscope. 32. (canceled) 33. The method of claim 14, wherein the pipette tip has an orifice aspect ratio ranging from about 3.5 to about 5. 34-41. (canceled)
※ AI-Helper는 부적절한 답변을 할 수 있습니다.